Read More Pharma Industry News Will payers embrace premium weight loss? Inside the reimbursement risks of next-gen GLP-1s As GLP‑1 weight‑loss drugs climb toward blockbuster status, insurers and payers face tough choices on coverage. Can premium weight‑loss therapies become mainstream? bySrinathDecember 2, 2025